Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. New York
    4. ›
  4. 10017
    5. ›
  5. FLUIDDA, INC.

FLUIDDA, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: FLUIDDA, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 15 Feb 2017 (8 years ago)
Entity Number: 5085574
ZIP code: 10017
County: New York
Place of Formation: Delaware
Address: 228 EAST 45TH ST, STE 9E, New York, NY, United States, 10017
Principal Address: 228 EAST 45TH STREET SUITE 9E, NEW YORK, NY, United States, 10017

Chief Executive Officer

Name Role Address
JAN DE BACKER Chief Executive Officer 228 EAST 45TH STREET SUITE 9E, NEW YORK, NY, United States, 10017

DOS Process Agent

Name Role Address
KIRKE MARSH DOS Process Agent 228 EAST 45TH ST, STE 9E, New York, NY, United States, 10017

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Phone Number:
646-258-3147
E-mail Address:
jan.debacker@fluidda.com
Contact Person:
JAN DE BACKER
User ID:
P2590774
Trade Name:
FLUIDDA INC

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
758B9
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2025-01-29
CAGE Expiration:
2030-01-29
SAM Expiration:
2026-01-28

Contact Information

POC:
JAN DE BACKER

Immediate Level Owner

Vendor Certified:
2025-01-29
CAGE number:
B7776
Company Name:
FLUIDDA

History

Start date End date Type Value
2025-02-03 2025-02-03 Address 228 EAST 45TH STREET SUITE 9E, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)
2023-02-23 2025-02-03 Address 228 EAST 45TH STREET SUITE 9E, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)
2023-02-23 2025-02-03 Address 228 EAST 45TH ST, STE 9E, New York, NY, 10017, USA (Type of address: Service of Process)
2023-02-23 2023-02-23 Address 228 EAST 45TH STREET SUITE 9E, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)
2019-11-14 2023-02-23 Address C/O TABS INC., 228 EAST 45TH STREET STE 9E, NEW YORK, NY, 10017, 3303, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
250203004911 2025-02-03 BIENNIAL STATEMENT 2025-02-03
230223002553 2023-02-23 BIENNIAL STATEMENT 2023-02-01
210202060044 2021-02-02 BIENNIAL STATEMENT 2021-02-01
191114060137 2019-11-14 BIENNIAL STATEMENT 2019-02-01
170215000053 2017-02-15 APPLICATION OF AUTHORITY 2017-02-15

USAspending Awards / Contracts

Procurement Instrument Identifier:
36C24224P1542
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
192225.00
Base And Exercised Options Value:
192225.00
Base And All Options Value:
192225.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2024-07-25
Description:
CT ANALYSIS CONTRACT NJ HEALTHCARE
Naics Code:
541690: OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
Product Or Service Code:
AJ11: GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH

USAspending Awards / Financial Assistance

Date:
2023-09-26
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
A PROSPECTIVE STUDY TO SUPPORT VALIDATION OF LUNG DEPOSITION MODELS WITH NUCLEAR MEDICINE IMAGING METHODS - PROJECT SUMMARY IN THIS PROJECT WE PROPOSE TO DEVELOP AND EXECUTE PROTOCOLS FOR A NUCLEAR IMAGING DEPOSITION STUDY USING EITHER SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) OR, PREFERABLY, POSITRON EMISSION TOMOGRAPHY (PET), WITH THE GOAL OF SUPPORTING VALIDATION OF IN-SILICO MODELS OF DEPOSITION. THESE PROTOCOLS, DEVELOPED IN COLLABORATION WITH THE FDA, WILL BE OPTIMIZED TO 1) COLLECT DATA WHICH MAY BE USED AS INPUT PARAMETERS FOR THE MODELS WHICH USE THIS DATA FOR VALIDATION PURPOSES AND 2) LEVERAGE RECENT ADVANCES IN SPECT AND PET TECHNOLOGY TO ACHIEVE IMAGES WITH SIGNIFICANTLY HIGHER SPATIAL AND TEMPORAL RESOLUTION THAN WAS PREVIOUSLY POSSIBLE. BUILDING ON APPROACHES DEVELOPED PRIMARILY BY RESEARCHERS FLEMING, MONTESANTOS, AND GREENBLATT, WE WILL DEVELOP METHODS TO DERIVE MORE ACCURATE ESTIMATIONS OF BRANCH-LEVEL DEPOSITION FROM THE RESULTING IMAGES BY 1) LEVERAGING OUR EXPERIENCE IN QUANTITATIVE CT SEGMENTATION OF LUNG STRUCTURE, 2) MAKING USE OF IMPROVEMENTS IN IMAGE RESOLUTION TO OPTIMIZE RADIOTRACER ACTIVITY LOCALIZATION WITHIN AIRWAYS AS SMALL AS THE 4TH GENERATION, 3) LOCALIZING RADIOTRACER ACTIVITY WITHIN ANATOMIC COMPARTMENTS OF THE LUNG AS SMALL AS THE SEGMENTAL LEVEL, AND 4) MORE ACCURATELY REFLECTING DISEASE-SPECIFIC VARIATIONS IN AIRWAY MORPHOLOGY WHICH VIOLATE KEY ASSUMPTIONS OF THE WORK OF FLEMING AND MONTESANTOS. THESE PROTOCOLS WILL BE DEVELOPED AND EXECUTED IN COLLABORATION WITH PERSONNEL FROM THE NUCLEAR MEDICINE AND RADIOLOGY AND PHARMACOLOGY FACULTY AT ERASMUS MEDICAL CENTER AS SUBAWARDEES. THESE RESEARCHERS WILL BE PRIMARILY RESPONSIBLE FOR DEVELOPING, VALIDATING, AND IMPLEMENTING A PROCESS TO PRODUCE A RADIOLABELED FORMULATION OF ONE ORALLY INHALED DRUG PRODUCT (OIDP) WHICH IS FIT-FOR-USE, AS WELL AS APPROPRIATE SPECT OR PET PROTOCOLS OPTIMIZED FOR THE NEEDS OF THE OVERALL PROJECT. HEALTHY VOLUNTEERS AND SUBJECTS WITH ASTHMA OR COPD WILL BE RECRUITED FROM A SINGLE CENTER LOCATED IN KONTICH, BELGIUM. BY RECRUITING SUBJECTS WITH ASTHMA AND COPD, WE HOPE TO DEVELOP METHODS WHICH CAN ACCOUNT FOR CLINICALLY SIGNIFICANT DIFFERENCES IN VENTILATION AND DEPOSITION WHICH ARE NOT ACCOUNTED FOR IN PREVIOUS WORK, SPECIFICALLY EMPHYSEMA AND GAS TRAPPING. THE RESULTING DATA, INCLUDING 1) STANDARDIZED PROTOCOLS AND PROCEDURES, 2) IMAGES ACQUIRED, 3) METHODS AND CODE, AND 4) RESULTS OF ANALYSIS WILL BE MADE AVAILABLE TO THE FDA TO DISSEMINATE PUBLICLY 18 MONTHS FOLLOWING COMPLETION OF THE STUDY, TO MEET THE OBJECTIVE OF PROVIDING DATA TO FACILITATE IN-SILICO MODEL VALIDATION.
Obligated Amount:
665121.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-02-16
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
134402.00
Total Face Value Of Loan:
134402.00
Date:
2020-06-26
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
104747.00
Total Face Value Of Loan:
104747.00

Paycheck Protection Program

Date Approved:
2020-06-26
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
104747
Current Approval Amount:
104747
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Non-Veteran
Forgiveness Amount:
105665.17
Date Approved:
2021-02-16
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
134402
Current Approval Amount:
134402
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Non-Veteran
Forgiveness Amount:
135327.66

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

KIRKE MARSH

LIBERIS US INC. VENTURA SYSTEMS, INC. CMNTY CORPORATION

Related by address

228 EAST 45TH ST, STE 9E, New York, NY, United States, 10017

APP4SALES INC. BEYUNA USA CORPORATION BIERENS COMMERCIAL COLLECTIONS, INC. BUREAU MIJKSENAAR USA INC. CAVUS INTERNATIONAL, INC. CMNTY CORPORATION CONTINIA SOFTWARE INC. ELLIS FAAS COSMETICS INC. FOLEON INC.

228 EAST 45TH STREET SUITE 9E, NEW YORK, NY, United States, 10017

ALPHA WAX USA CORPORATION ASSISTIVE INNOVATIONS CORP. BEYUNA USA CORPORATION DEKKERS NORTH AMERICA INC. DESIGNTUBE LLC FOLEON INC. GYNZY INC. HFC USA, INC. ICE USA INC.

Date of last update: 24 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated